In utero aminoglycosides-Induced nephrotoxicity in rat neonates. Pregnant Wistar females were treated with gentamicin (G), netilmicin (N) or amikacin (A) during two periods of pregnancy covering organogenesis and the beginning of nephrogenesis. Deliveries occurred normally. We studied functional effects-influence of sex, litter size, diuresis, creatmine clearance, 0-kidney concentration, and kidney morphological alterations-in rat neonates on day 1 of life. After 0 and N, the creatinine clearance of the neonates was decreased according to the dosage given to the mother. Whatever the aminoglycoside, kidneys presented proximal tubular alterations (close to those observed in adults) at protonic microscopy and, with electron microscopy, some modifications of distal tubules and of mature and immature glomeruli. It is concluded that the developing kidney can be altered after treating pregnant mothers with aminoglycosides. This model of in utero-induced nephrotoxicity is dose-dependent. Mature and/or immature structures could be affected. The toxicity of the investigated antibiotics could be asserted as G N > A.
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The effect upon the neonate's kidney of drugs given during pregnancy is rarely scrutinized [1] [2] [3] [4] [5] [6] [7] [8] . Toxicologic studies are usually considered acceptable when animal reproduction is possible and leads to apparently normal offspring presenting normal weaning, growth, and reproductive capability [9, 10] .
Teratological defects resulting from the use of modern drugs are rarely reported and little attention is currently being paid to the kidney. Nevertheless, it seems logical that a drug having a renal effect in the mother, and able to cross the placental barrier, would also have a renal effect in the fetus and/or in the neonate.
Such an effect would probably remain hidden from routine toxicological studies [11] [12] [13] .
Due to particularities of the developing kidney [14] [15] [16] [17] , the period of drug administration during the pregnancy, and duration of treatment, this possible fetal renal effect could affect either developed or developing structures [18] . One of us reported previously that gentamicin given to pregnant rats leads to kidney morphological alterations in neonates which presented a slowing down of the maturation and, moreover, an in utero-acquired nephrotoxicity [19] [20] [21] .
The purpose of this study was to investigate the renal function during this gentamicin nephrotoxicity. In addition, the Received for publication July 11, 1986 and in revised form August 28, 1987 © 1988 by the International Society of Nephrology histopathological and functional effects of two widely used aminoglycosides (netilmicin and amikacin) were studied. In an attempt to present simultaneous evidence for this in uteroacquired nephrotoxicity, the gentamicin concentration was measured in neonate kidneys. Investigations were also conducted on the mother at the time of delivery, but only to be sure that the observed neonate's status was not an affect of an eventual maternal renal failure.
Gentamicin was given at three different dosages (25, 50 or 75 mg/kg) in order to search for a possible dose-dependent effect. The dosage of netilmicin (60 mg/kg) was lower than the more nephrotoxic dosage of gentamicin (75 mg/kg). The dosage ratio of netilmicin to amikacin (180 mg/kg) was chosen to obtain equally potent bactericidal activity [22, 23] . In addition, some experiments were conducted using a very low dose of gentamicm (7.5 mg/kg) or a high dose of amikacin (250 mg/kg). The nephrotoxicity of these dosages will be discussed later.
Antibiotics were given during two periods of the pregnancy in each experiment: the organogenesis and the beginning of the nephrogenesis. They were never administered during the last two days before delivery.
Methods

General protocol Constitution of groups. Groups of pregnant and non-pregnant
Wistar rats were used.
The first group of females were mated with males, and day I of pregnancy was defined as the day that sperm was found in vaginal smear.
For non-pregnant rats, females were isolated from males, housed in the laboratory, and treated in the same way as were pregnant animals.
Treatment. Pregnant and non-pregnant females were then allocated into sub-groups: control (C), gentamicin 75 mg/kg (G75), 50 mg/kg (050), 25 mg/kg (G25) or 7.5 mg/kg (G7.5), netilmicin 60 mg/kg (N), and amikacin 180 mg/kg (A 180) or 250 mg/kg (A250) ( Table 1) .
Drugs were given during the second week of pregnancy (or of observation for the non-pregnant groups), on days 7 to 11, and during the third week on days 14 to 18. Dosages were calculated each day after determining the body weight and were administered by subcutaneous injection between 3:00 and 5:00 p.m. Commercial preparations of antibiotic solutions were used: Allowed to litter gentamicin (Gentalline, Laboratoires Unicet), netilmicin (Netromicine, Laboratoires Unicet) and amikacin (Amiklin, Laboratoires Bristol).
On the same days, pregnant and non-pregnant C females were given a similar volume of saline serum (0.7%) by the same method. Selection of litters and maternal biology. In this strain, birth normally occurs on the afternoon of the twenty-second day of gestation; the day after is considered day I of life.
Several mothers taken at random from each sub-group were sacrificed shortly after the birth, together with all the nonpregnant females. Blood samples were taken by cardiac puncture and centrifuged. Other mothers were allowed to litter (Table 1 ). Plasmas were analyzed for Na and K using a flame emission spectrophotometer (Instrument Laboratory IL 243, Paris, France), for BUN and creatinine with an automatic analyzer (ABA 100, Laboratoires Abbot, Paris, France), and for protein with a refractometer.
Renal function measurements in neonates
On day 1 of life, the neonates were subjected to a basal clearance evaluation following techniques described by Kaylock and Gray [24, 251 and Kaviock et al [26, 27] . After the bladders had been voided, the pups were kept for three hours in a specially designed device. They were housed separately in beakers placed in a water bath to keep the surface of the bedding at 32 to 34°C in an humidity saturated atmosphere. At the end of the period, the bladders were voided again and urine quantitatively collected in calibrated tubes. The pups were weighed. The kidneys were quickly removed by opening the flank, then trunk blood was collected into Serum Separator tubes (Becton Dickinson) after decapitation. Due to the small amount of blood samples, only creatinine and protein levels were measured.
Diuresis was stated per hour per gram of body weight.
Creatinine clearance (Car) and FE H2O were calculated using the standard formula.
Pathology
Females. In several treated females, pregnant and nonpregnant, the kidneys were removed and a routine pathological examination ( Table 1 ) was performed to verily the presence and the intensity of well known features of aminoglycoside nephrotoxicity [28, 291. Neonates. Fifty-three random neonates from 64 litters were histopathologically examined at the end of the clearance period prior to decapitation (Table 1) .
After opening the flank, glutaraldehyde was immediately dripped on the left kidney, which was then transferred into vials containing glutaraldehyde and cut into 1 mm3 blocks. These fragments were fixed in 2% glutaraldehyde in 0.2 M cacodylate buffer (pH 7.4) for two hours. The fragments were then rinsed in saccharose and post-fixed for one hour in 1% osmium oxyde.
After dehydration in graded ethanol solutions, tissue blocks were embedded in Epon 812. Semithin sections (1 ) were stained with toluidine blue; ultrathin sections were stained with uranyl acetate and lead citrate (LKB ultrastainer) and examined at 60 KV in a Philips EM 301 electron microscope.
The right kidney was removed without dripping and transferred into fixative (Dubosq-Brazil) for 24 hours. After embedding in Paraplast, it was sliced into 2 sm cuts and then stained with hematotoxylin, eosin, light green trichome, Schiff periodic-acid and silver methenamine.
Kidney concentration of gentamicin
Renal gentamicin concentrations were assayed microbiologically by an Agar diffusion technique using bacillus subtillis ATCC 6633 as a test organism. The detection limit was 0.049 jg/m1. Each kidney was homogenized individually in sterile 0.01 M phosphate buffer pH 8.0 (1:10 wt/vol) using a kontess conical sintered, glass tissue grinder. Each determination was done in triplicate at two dilutions. Results are expressed as g of gentamicin per gram of wet tissue.
Statistics
Results are given as means SEM. For each criterium, a multifactorial analysis was performed using SPSS-X Information System (Statistical Package for Social Sciences) with a DPS-8 BULL system (Multics). When a significant difference in a group was found for one or more treatments a paired t-test was applied. Results as mean SEM, vs. C: "P < 0.05, b < 0.01, <0.001
Results
Females
Blood biology. Results are reported in Table 2 . Pregnant rats presented no acute renal failure after gentamicin, netilniicin, or amikacin. Non-pregnant rats presented a hypoproteinemia after either G, N, or A.
Pathology. All animals presented various grades of kidney alterations; however, the degree was rarely severe in pregnant rats. These aspects are similar to the currently known pathological features of experimental nephrotoxicity [28, 291. Neonates Functional effects. The sex did not affect the results whatever the parameter or the group (N males, 205; females, 201). No significant difference was noted in the mean number of pups in each group (Table 1) .
With high dosages of gentamicin (Table 3) , G75 pups were smaller than C neonates (P < 0.001) Creatinine clearance was lower (P < 0.001), due to a lower diuresis (P < 0.01), a lower urine creatinine concentration (NS) and a higher blood creati nine concentration (P < 0.001), (Fig. 1) .
In intermediate dosages of gentamicin, U/P creatinine ratios were lower in G25 (P < 0.05) and G50 (P < 0.05) than in C pups. ifowever. creatinine clearance was unaffected in G25, but lower in G50 (P < 0.01). The latter was intermediate between C or G25 and G75 values (Fig. 2) .
Creatinine clearance was lower in N60 taking netilmicin than in C group (P < 0.01), with a lower U/P creatinine ratio (P < 0.05) and a higher PC, (P < 0.001). These values were close to those of the G50.
A180 pups taking amikacin presented a lower creatinine urine concentration than C (P < 0.05). As compared to the C group, A250 neonates were smaller (P < 0.001); they had a lower diuresis (P < 0.001) and a higher creatinine urine concentration (P < 0.001), creatinine excretion (P < 0.05) and U/P creatinine ratio (P < 0.05).
Pathology. Proximal tubules of mature nephrons (fully functional nephrons of the juxtamedullary area, standard sections of 2r) exhibited degenerative alterations which varied in severity and extent. Cells were swollen, cytoplasm was cloudy, and there were numerous vacuoles and often PAS-positive inclusions. Sometimes an atrophy of the brush border, an epithelial flattening and/or an enlargement of lumen were observed.
Necrosis was rarely present. There was no evidence of regeneration and mitoses in proximal tubules but mitoses were very numerous in collecting ducts and undifferentiated nephrons. Glomeruli, distal tubules and collecting ducts appeared normal.
Electron microscopy showed that lesions were of the same type whatever the drug, but most of them were dependent on the dosage.
Alterations of proximal tubules were mild, focal, seen only in mature nephrons, and were mainly modifications of the lysosoma! system (increase in number and size of phagosomes and lysosomes, cytosome coalescence with autophagic vacuoles, Figs. 3 and 4 ). Lysosomes were heterogeneous: clear and granulated, dense with various opaque areas, or figuring large and empty vacuoles. Myelin figures or myeloid bodies were observed in lysosomes, in mitochondria, free in the hyaloplasm, or in the tubular lumen. These figures were unusual in the control's kidneys, but they were very numerous after aminoglycosides whatever the drug, increasing according to the dosage. Mitochondrial modifications were rare and usually present as coalescence with lysosomes. The brush border was atrophic and it disappeared in several cases where cells presented a protruding apical pole, poor in organites (Fig. 5) . Focal necrosis and cell desquamation were exceptional.
Mature or immature glomeruli presented, depending on the dosage, with myelin figures and autophagic vacuoles (Figs. 6 and 7) . In differentiated distal tubules myeloid bodies were also present. For one kidney, seven parameters were graded and added up.
Repartition of the sums according to the treatment.
Since the features of morphological effects of aminoglycosides were not very different, we tried to quantify them in order to assess possible differences.
Using semithin sections, seven parameters were investigated: lumen dilations, altered brush borders, apical protrusion, clear vacuoles, lysosomal hypertrophy, luminal casts, and myeloid bodies. They were graded: 0, absence; I, moderate presence; 2, sizable presence. For each kidney, the seven marks were added up, and the sums were then alloted to seven possible classes. Table 4 shows the number of occurrences in each class.
Mult(factorial analysis. The Bonferoni test was used to compare groups one by one with each other for nine parameters ( Table 5) . Differences were considered significant if P < 0.05. A progression was noted in G groups: G75 presented four differences compared to C, three to G25 and one to G50. The widest range of differences was observed in A250. N60 was close to G50. A180 was close to G25 and G50 but presented no difference compared to C. Creatinine clearance was different when C group was compared to G50, G75 or N60, but not when compared to G25 or A groups.
Kidney concentration of gentamicin. Results are reported in Table 6 .
Discussion
Aminoglycoside nephrotoxicity has been demonstrated to follow an almost predictable clinical and functional course in human and animal studies [30-351, associated with a reproducible sequence of ultrastructural changes in renal tubular cells [28, 29, [36] [37] [38] [39] and directly related to an accumulation of aminoglycosides within the renal cortex [31, 40, 41] . Our findings are consistent with the main aspects of this toxicity.
The dosages of aminoglycosides given to the rats seem very high compared to those used in humans; however, when they are compared with body surface area, the differences are less prominent, and are close to differences in GFR/BSA. Moreover, while the size of the nephron is marginally smaller in the rat than in man, when expressed by grams of body weight the number of nephrons is about tenfold in the rat, suggesting a larger reabsorption area and greater GFR [42] [43] . In the same way, differences of sensitivity have been reported depending on the rat strain or on subpopulations in the same strain [44] .
The originality of this model is that the animal suffering this toxicity has not received the drugs directly, but from the mother through the placenta, and that the altered kidney is still immature, presenting both differentiated and undifferentiated struc- tures [17] . In previous studies the kidneys of infants seemed to be less vulnerable, and aminoglycosides administered during pregnancy were never shown to be nephrotoxic for the fetus [3, [9] [10] [11] [12] [13] 45] . Moreover, this therapy has been recommended for treatment of intra-uterine infections [46] . Indeed, an acquired insensitivity of new cells of the proximal tubules after necrosis to further gentamicin administration has been reported [47] , and a less severe degree of sensitivity of the immature kidney was found in the rabbit [48] and in the rat [491. However, Von Husstedt et a! claimed that gentamicin could be dangerous for the fetus when given to pregnant women [50] , and the kidneys of neonates or infants could be altered after aminoglycosides were given directly to the subject either clinically [5 1-53] or experimentally [18, 21, 54] . Our results demonstrate a nephrotoxicity in the neonates after aminoglycosides have been given to the mother.
Uremic women or females in experimental uremia give birth to neonates with an impaired development [551. In our study, the drug dosages used and the timing of the injections were not followed by a significant rise of creatinemia or BUN in pregnant females on the day of delivery. Moreover, the small modifications noted were less noticeable in the pregnant than in the non-pregnant groups. This can probably be explained by the adaptation of the rat kidneys to pregnancy and the increase of GFR [56-581. Gentamicin is present in the neonate's kidneys in a concen-I I Fig tration which seems to be relatively independent of the dosage given to the mothers, and lower than that usually reported in adults [40, 411 . This is probably explained by one or more of the following factors: 1) The neonatal rat kidney is not mature for the first 12 to 15 days of life; thus the kidney weight corresponds to both mature and immature structures. 2) For gentamicin to be incorporated in proximal tubular cells, it needs to be filtered and then absorbed through the brush border [31, 58] . Therefore gentamicin could reach the tubular cells only in fully differentiated nephrons. 3) The total amount of the drug is partly excreted and partly incorporated into the tissues of the mother.
Only a small portion crosses the placental barrier and is then diluted into several feto-placental units.
Pathology shows that aminoglycosides can alter the glomeruli whatever the age of differentiation. Nevertheless tubular alterations are clearly seen only in differentiated nephrons, comparable mainly to those reported either in adults [28, 29, 39, 59] or in neonates [18] . The toxicity of the three aminoglycosides cannot be distinguished; morphological effects are only dependent on the dosage, and very small modifications are even seen after the very low dosage of gentamicin (Table 4 , Fig. 7) .
A progressive alteration of the creatinine clearance is noted according to the dose of gentamicin. The effect of the 60 mg dosage of netilmicin is close to that of the 50 mg dose of gentamicin, in agreement with the equivalent nephrotoxicity generally reported for these two atninoglycosides.
The low dosage of gentamicin (025) is not followed by a modification of the creatinine clearance. We are inclined to think that the G25 toxicity is equivalent to a low or a mild aminoglycoside nephrotoxicity in humans, while G50, G75 and N60 dosages are responsible for damages too severe to induce polyuria, but not severe enough to produce oliguria.
The effects of amikacin are not very marked. The Al80 group shows no decrease of the clearance, this dose is considered to have a bactericidal activity equipotent to the 60 mg dose of netilmicin [22, 23] . Surprisingly the A250 group presents a normal clearance, resulting from a very high urinary concentration of creatinine, despite a significant fall in diuresis. We could speculate that these animals have had poorer functions in Table 6 . Thus the apparently normal GFR may be the result of a "washing out" of previously increased plasma values. It could also result from a tubular leakage; pathology gives no evidence in favor of or against this hypothesis. In this case the creatinine clearance might not be a good index of GFR.
Thus the progression of functional alterations, according to the dosages, is comparable to the progression of morphological modifications for G and N. Taking into account results in graded comparisons (Table 4) , morphological aspects and functional performances, the toxicity of the three investigated aminoglycosides could be asserted as follows: gentamicin netilmicin> amikacin. This rank order for toxicity is different from that observed in adult animals 160, 611.
In conclusion, pathological and functional findings demonstrate that the developing kidney (male or female) can be altered after treatment of the pregnant mother with aminoglycosides. This in utero nephrotoxicity raises the question of the quality of the future maturation and degree of recovery, and needs further investigation.
Such an experimental model is strongly dose-dependent and moderately drug-dependent. it includes a broad field of investigation because many of the different kidney functions of the rat neonate have just developed or are still developing, and the quality of the final adult kidney could be threatened by in utero exposure to drugs.
